Publications by authors named "N M Acquisto"
Evaluation of risk factors associated with acute kidney injury in a level IV regional NICU.
J Neonatal Perinatal Med
November 2024
Background: Intervening on neonates at risk for developing acute kidney injury (AKI) improves safety and clinical outcomes. This study sought to evaluate risk factors associated with AKI in a level IV neonatal intensive care unit (NICU).
Methods: Single-center, case-control study of patients with corrected gestational age (GA) ≤44 weeks from 2018 to 2022.
Background: Intravenous (IV) diltiazem and metoprolol are commonly used to achieve rate control for atrial fibrillation with RVR (Afib with RVR), and are both recommended as first-line by current guidelines. While prior studies investigated the efficacy of these medications, there is little evidence available regarding the risk of adverse events (AEs) with their use.
Methods: We identified randomized controlled trials (RCT) and observational studies reporting rates of AEs following administration of IV diltiazem and metoprolol for Afib with RVR by searching PubMed, SCOPUS, EMBASE, and Cochrane Library.
In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.
View Article and Find Full Text PDFPurpose: We implemented a "kit in hand" naloxone distribution program at emergency department (ED) discharge activated by electronic health record Best Practice Advisory (BPA). The purpose of this study was to evaluate naloxone kit distribution before and after implementation.
Methods: Retrospective observational study of adult ED patients with unintentional opioid overdose conducted over a six-month period.
Article Synopsis
- Acute bacterial skin and skin structure infections (ABSSSI) are a significant issue for the healthcare system, and using single-dose lipoglycopeptides (LGPs) like dalbavancin or oritavancin in the emergency department can help manage these infections in low-risk patients.
- *Limited studies suggest that administering these antibiotics in the ED reduces hospital stays, revisits, and costs while improving patient satisfaction; however, there's a need for more data on patient selection and treatment outcomes.
- *The review discusses the potential benefits of LGPs in avoiding hospitalizations and expediting discharges for patients with ABSSSI, while also addressing the gaps in research regarding their overall effectiveness and impact on patient quality of life.